Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 4
1979 4
1980 4
1981 1
1983 1
1984 2
1988 5
1989 1
1990 2
1991 4
1993 2
1995 1
1997 1
2005 1
2006 8
2007 7
2008 6
2009 4
2010 3
2011 7
2012 3
2013 4
2014 2
2015 1
2016 3
2017 1
2018 2
2019 1
2020 2
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA. Verma S, et al. Among authors: fitchett dh. Circulation. 2019 Nov 19;140(21):1693-1702. doi: 10.1161/CIRCULATIONAHA.119.042375. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434508 Clinical Trial.
Management of Acute Coronary Syndromes.
Diabetes Canada Clinical Practice Guidelines Expert Committee; Tardif JC, L'Allier PL, Fitchett DH. Diabetes Canada Clinical Practice Guidelines Expert Committee, et al. Among authors: fitchett dh. Can J Diabetes. 2018 Apr;42 Suppl 1:S190-S195. doi: 10.1016/j.jcjd.2017.10.029. Can J Diabetes. 2018. PMID: 29650095 No abstract available.
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.
Cardiometabolic Risk Working Group: Executive Committee; Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E. Cardiometabolic Risk Working Group: Executive Committee, et al. Among authors: fitchett dh. Can J Cardiol. 2011 Mar-Apr;27(2):e1-e33. doi: 10.1016/j.cjca.2010.12.054. Can J Cardiol. 2011. PMID: 21459257 Review.
Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.
Fitchett DH, Borgundvaag B, Cantor W, Cohen E, Dhingra S, Fremes S, Gupta M, Heffernan M, Kertland H, Husain M, Langer A, Letovsky E, Goodman SG; Renewal of Non STE ACS Algorism Group. Fitchett DH, et al. Can J Cardiol. 2006 Jun;22(8):663-77. doi: 10.1016/s0828-282x(06)70935-7. Can J Cardiol. 2006. PMID: 16801997 Free PMC article. Review.
Cardiology patient page. Statin intolerance.
Fitchett DH, Hegele RA, Verma S. Fitchett DH, et al. Circulation. 2015 Mar 31;131(13):e389-91. doi: 10.1161/CIRCULATIONAHA.114.013189. Circulation. 2015. PMID: 25825402 No abstract available.
90 results